Classical Human Leukocyte Antigen Alleles and C4 Haplotypes Are Not Significantly Associated With Depression
The prevalence of depression is higher in individuals with autoimmune diseases, but the mechanisms underlying the observed comorbidities are unknown. Shared genetic etiology is a plausible explanation for the overlap, and in this study we tested whether genetic variation in the major histocompatibil...
Saved in:
Published in | Biological psychiatry (1969) Vol. 87; no. 5; pp. 419 - 430 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.03.2020
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The prevalence of depression is higher in individuals with autoimmune diseases, but the mechanisms underlying the observed comorbidities are unknown. Shared genetic etiology is a plausible explanation for the overlap, and in this study we tested whether genetic variation in the major histocompatibility complex (MHC), which is associated with risk for autoimmune diseases, is also associated with risk for depression.
We fine-mapped the classical MHC (chr6: 29.6–33.1 Mb), imputing 216 human leukocyte antigen (HLA) alleles and 4 complement component 4 (C4) haplotypes in studies from the Psychiatric Genomics Consortium Major Depressive Disorder Working Group and the UK Biobank. The total sample size was 45,149 depression cases and 86,698 controls. We tested for association between depression status and imputed MHC variants, applying both a region-wide significance threshold (3.9 × 10−6) and a candidate threshold (1.6 × 10−4).
No HLA alleles or C4 haplotypes were associated with depression at the region-wide threshold. HLA-B*08:01 was associated with modest protection for depression at the candidate threshold for testing in HLA genes in the meta-analysis (odds ratio = 0.98, 95% confidence interval = 0.97–0.99).
We found no evidence that an increased risk for depression was conferred by HLA alleles, which play a major role in the genetic susceptibility to autoimmune diseases, or C4 haplotypes, which are strongly associated with schizophrenia. These results suggest that any HLA or C4 variants associated with depression either are rare or have very modest effect sizes. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 PMCID: PMC7001040 Human Genetics and Computational Biomedicine, Pfizer Global Research and Development, Groton, Connecticut NIHR Maudsley Biomedical Research Centre, King's College London, London, United Kingdom Computational Sciences Center of Emphasis, Pfizer Global Research and Development, Cambridge, Massachusetts iSEQ, Centre for Integrative Sequencing, Aarhus University, Aarhus, Denmark National Centre for Register-Based Research, Aarhus University, Aarhus, Denmark Department of Psychological Medicine, University of Worcester, Worcester, United Kingdom Department of Psychiatry, Kaiser Permanente Northern California, San Francisco, California University of Liverpool, Liverpool, United Kingdom Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Niedersachsen, Germany Institute for Molecular Bioscience, Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia Child Health Research Centre, University of Queensland, Brisbane, Queensland, Australia Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California Bioinformatics, University of British Columbia, Vancouver, British Columbia, Canada Department of Mental Health, National Health Service, Glasgow, United Kingdom Department of Genetic Epidemiology in Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Baden-Württemberg, Germany DZHK (German Centre for Cardiovascular Research), Partner Site Greifswald, University Medicine, University Medicine Greifswald, Greifswald, Germany School of Psychology and Counseling, Queensland University of Technology, Brisbane, Queensland, Australia Discipline of Psychiatry, University of Adelaide, Adelaide, South Australia, Australia Department of Biomedical Informatics, Harvard Medical School, Boston, Massahusetts Virginia Institute for Psychiatric and Behavior Genetics, Richmond, Virginia Department of Epidemiology, Erasmus MC, Rotterdam, Zuid-Holland, The Netherlands Department of Psychiatry, Columbia University College of Physicians and Surgeons, New York, New York Department of Statistical Genomics and Systems Genetics, European Bioinformatics Institute (EMBL-EBI), Cambridge, United Kingdom Bioinformatics Research Centre, Aarhus University, Aarhus, Denmark Division of Psychiatry, University of Edinburgh, Edinburgh, United Kingdom Department of Biomedicine, University of Basel, Basel, Switzerland deCODE Genetics/Amgen, Reykjavik, Iceland Institute of Neuroscience and Medicine (INM-1), Research Center Juelich, Juelich, Germany Department of Psychiatry, University Hospital of Lausanne, Prilly, Switzerland Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, United Kingdom Department of Neuroscience and Mental Health, Cardiff University, Cardiff, United Kingdom Department of Psychiatry, Trinity College Dublin, Dublin, Ireland Department of Biomedicine, Aarhus University, Aarhus, Denmark Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark Max Planck Institute of Psychiatry, Munich, Germany Department of Psychiatry, Psychosomatics and Psychotherapy, University of Wurzburg, Wurzburg, Germany Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia Internal Medicine, Erasmus MC, Rotterdam, Zuid-Holland, The Netherlands Department of Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts Department of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, Maryland Centre for Addiction and Mental Health, Toronto, Ontario, Canada Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts Department of Clinical Medicine, Translational Neuropsychiatry Unit, Aarhus University, Aarhus, Denmark Munich Cluster for Systems Neurology (SyNergy), Munich, Germany Queensland Brain Institute, The University of Queensland, Brisbane, Queensland, Australia Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom Division of Psychiatry, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom Danish Headache Centre, Department of Neurology, Rigshospitalet, Glostrup, Denmark Centre for Integrative Biology, Università degli Studi di Trento, Trento, Trentino-Alto Adige, Italy Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University Munich, Munich, Germany Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Department of Psychiatry, Vrije Universiteit Medical Center and GGZ inGeest, Amsterdam, The Netherlands Department of Human Genetics, Wellcome Trust Sanger Institute, Cambridge, United Kingdom Stanley Center for Psychiatric Research, Broad Institute, Cambridge, Massachusetts Department of Statistics, University of Oxford, Oxford, United Kingdom Division of Psychiatry, University College London, London, United Kingdom Psychiatry, Harvard Medical School, Boston, Massachusetts Department of Psychiatry, Virginia Commonwealth University, Richmond, Virginia Department of Psychiatry and the Behavioral Sciences, University of Southern California, Los Angeles, California Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden Psychiatry, Erasmus MC, Rotterdam, Zuid-Holland, The Netherlands Centre for Integrated Register-based Research, Aarhus University, Aarhus, Denmark Department of Statistics, University of British Columbia, Vancouver, British Columbia, Canada Institute of Molecular and Cell Biology, University of Tartu, Tartu, Estonia Medical Research Council Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom Child and Youth Mental Health Service, Children's Health Queensland Hospital and Health Service, South Brisbane, Queensland, Australia Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia Department of Psychiatry, Washington University in Saint Louis School of Medicine, Saint Louis, Missouri Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany Department of Psychiatry, University of California, San Diego, San Diego, California Institute of Biological Psychiatry, Mental Health Center Sct. Hans, Mental Health Services Capital Region of Denmark, Copenhagen, Denmark Department of Psychological Medicine, Cardiff University, Cardiff, United Kingdom iPSYCH, The Lundbeck Foundation Initiative for Integrative Psychiatric Research, Aarhus, Denmark Brain and Mind Centre, University of Sydney, Sydney, New South Wales, Australia Faculty of Medicine, Department of Psychiatry, University of Iceland, Reykjavik, Iceland Division of Epidemiology, New York State Psychiatric Institute, New York, New York Department of Psychiatry, Melbourne Medical School, University of Melbourne, Melbourne, Victoria, Australia Social, Genetic and Developmental Psychiatry Centre, King's College London, London, United Kingdom Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany Department of Medical & Molecular Genetics, King's College London, London, United Kingdom Deptartment of Biological Psychology and EMGO+ Institute for Health and Care Research, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, United Kingdom Institute of Human Genetics, University of Bonn, School of Medicine & University Hospital Bonn, Bonn, Germany Complex Trait Genetics, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands Medical Genetics Section, CGEM, IGMM, University of Edinburgh, Edinburgh, United Kingdom Department of Psychiatry, University of Münster, Münster, Germany Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts Center for Neonatal Screening, Department for Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark Department of Psychiatry (UPK), University of Basel, Basel, Switzerland Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom Amsterdam Public Health Institute, Vrije Universiteit Medical Center, Amsterdam, The Netherlands Department of Psychiatry and Psychotherapy, Medical Center–University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina College of Biomedical and Life Sciences, Cardiff University, Cardiff, United Kingdom Florey Institute for Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia Center for NeuroModulation, Faculty of Medicine, University of Freiburg, Freiburg, Germany Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland Department of Psychiatry and Behavioral Sciences, Emory Universi |
ISSN: | 0006-3223 1873-2402 1873-2402 |
DOI: | 10.1016/j.biopsych.2019.06.031 |